Overcoming negative predictions of microRNA expressions to gemcita-bine response with FOLFIRINOX in advanced pancreatic cancer patients.

Schlick, K; Hohla, F; Hamacher, F; Hackl, H; Hufnagl, C; Markus, S; Magnes, T; Gampenrieder, SP; Melchardt, T; Stattner, S; Hauser-Kronberger, C; Greil, R; Rinnerthaler, G.
Future Sci OA. 2020 Nov 30;7(2):FSO644. doi: 10.2144/fsoa-2020-0128.